Publications

5802 Results

Survival outcomes and risk group validation from SWOG S0925, a randomized phase II study of cixutumumab in new metastatic hormone-sensitive prostate cancer

Authors
R Wong;M Duong;C Tangen;N Agarwal;H Cheng;N Vogelzang;M Hussain;I Thompson;D Quinn;E Yu
Journal / Conference
Prostate Cancer and Prostatic Disease Sep;23(3):486-493; Feb 13. doi: 10.1038/s41391-020-0210-x. [Epub ahead of print]
Year
2020
Research Committee(s)
Genitourinary
PMID
PMID32055002
PMC
PMC7423720
Study Number(s)
S0925

Enrollment of adolescents and young adults onto SWOG cancer research network clinical trials: A comparative analysis by treatment site and era

Authors
ME Roth;JM Unger;AM O'Mara;MA Lewis;T Budd;RH Johnson;BH Pollock;CD Blanke;DR Freyer
Journal / Conference
Cancer Med. 2020 Mar;9(6):2146-2152
Year
2020
Research Committee(s)
Multiple sites
PMID
PMID32009305
PMC
PMC7064039

The SWOG Latin America Initiative is a long-standing effort to achieve Latino inclusion to Cancer Clinical Trials and Building a Culture for Research in Latin America

Authors
J Crowley;C Malloy;A Mohar;LG Mora-Garcia;M Lopez;S Basse
Journal / Conference
International Conference on Advancing the Science of Cancer in Latinos (Feb 26-28, 2020, San Antonio, TX), poster
Year
2020
Research Committee(s)
Cancer Care Delivery

Sociocultural Factors of Cancer Clinical Trial Recruitment and Multidisciplinary Team Recruitment of Latin-American Patients in Mexico, Peru and Colombia

Authors
D Isla;R Krouse;A Mohar;A Leon;M Sanchez;O Guevara;M Lopez;LG Mora;N Macavilca;IC Carrillo
Journal / Conference
International Conference on Advancing the Science of Cancer in Latinos (Feb 26-28, 2020, San Antonio, TX), poster
Year
2020
Research Committee(s)
Palliative Care
Study Number(s)
S1316

Clinical Trials in the Era of Digital Engagement: A SWOG Call to Action

Authors
K Gunturu;D Dizon;J Johnson;AM Mercurio;G Mason;D Sparks;W Lawton;J Klemp
Journal / Conference
JCO Clinical Cancer Informatics Mar; 4:254-258
Year
2020
Research Committee(s)
Cancer Care Delivery
PMID
PMID32191544
PMC
PMC7113134

A primer for cancer research programs on defining and evaluating the catchment area and evaluating minority clinical trials recruitment [book chapter]

Authors
L Nguyen;E Cook
Journal / Conference
Advances in Cancer Research Volume 146, Chapter 10, Pages 219-226
Year
2020
Research Committee(s)
Cancer Care Delivery

Association of immunophenotype with expression of topoisomerase II a and B in adult acute myeloid leukemia

Authors
A Michelson;S Mcdonough;C Willman;E Koegle;J Anderson;J Godwin;S Petersdorf;A List;M Othus;F Appelbaum;J Radich;R Ganapathi;A Advani;R Ganapathi
Journal / Conference
Scientific Reports Mar 26;10(1):5486
Year
2020
Research Committee(s)
Leukemia
PMID
PMID32218491
PMC
PMC7099013
Study Number(s)
SWOG-9031, SWOG-9126, SWOG-9333, SWOG-9500

Randomized Phase II Trial (SWOG S1310) of Single Agent MEK Inhibitor Trametinib vs 5-Fluorouracil or Capecitabine in Refractory Advanced Biliary Cancer

Authors
R Kim;S McDonough;A El-Khoueiry;T Bekaii-Saab;S Stein;V Sahai;G Keogh;E Kim;A Baron;A Siegel;A Barzi;K Guthrie;M Javle;H Hochster
Journal / Conference
European Journal of Cancer May;130:219-227
Year
2020
Research Committee(s)
Gastrointestinal
PMID
PMID32234665
PMC
PMC7539324
Study Number(s)
S1310

Analysis of pre- and post-treatment tissues from the SWOG S0800 trial reveals an effect of neoadjuvant chemotherapy on the breast cancer genome

Authors
R Powles;V Wali;X Li;W Barlow;Z Nahleh;A Thompson;A Godwin;C Hatzis;L Pusztai
Journal / Conference
Clinical Cancer Research Apr 15;26(8):1977-1984; Jan 9. doi: 10.1158/1078-0432.CCR-19-2405. Online ahead of print.
Year
2020
Research Committee(s)
Breast
PMID
PMID31919134
PMC
PMC771064
Study Number(s)
S0800

Vitamin D Pathway and Other Related Polymorphisms and Risk of Prostate Cancer: Results from the Prostate Cancer Prevention Trial

Authors
KC Torkko;C Till;CM Tangen;P Goodman;JM Schenk Kisser;X Song;MS Lucia;A van Bokhoven;U Peters;IM Thompson;ML Neuhouser
Journal / Conference
Cancer Prevention Research Jun;13(6):521-530; Feb 26;canprevres.0413.2019. doi: 10.1158/1940-6207.CAPR-19-0413
Year
2020
Research Committee(s)
Cancer Control
PMID
PMID32102946
PMC
PMC7272271
Study Number(s)
SWOG-9217